Bilastine for the treatment of allergic rhinoconjunctivitis and urticaria: results from an international Delphi study

• Egile Nagusiak: Giorgio Walter Canonica (Egilea), Piotr Kuna (Egilea), Marcus Maurer (Egilea), Ralph Mösges (Egilea), Zoltan Novak (Egilea), Nikolaus Papadopoulos (Egilea), Pablo Rodriguez del Rio (Egilea), the Delphi Study Group (Egilea)
• Formatua: Liburua
• Argitaratua: BioExcel Publishing Ltd, 2024-05-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: Second-generation oral H1-antihistamines, including bilastine, represent the emerging treatments of allergic rhinitis (including rhinoconjunctivitis) and chronic urticaria in both adults and children. This study analyses available evidence supporting the use of bilastine amongst second-g...